Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01681 CONSUN PHARMA
RT Nominal up8.620 +0.350 (+4.232%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties14,634-3.259%15,12715,62016,12116,651
Property, plant, equip. & others739,056-0.959%746,213724,633675,773661,309
Land & other Lease Assets124,652-3.210%128,786133,815123,675126,808
Intangible Assets283,140-9.222%311,904341,664371,423396,071
Interests in Asso. & JCEs0--0000
Other Non-current Assets68,4321.113%67,67991,177104,56497,599

1,229,914-3.134%1,269,7091,306,9091,291,5561,298,438
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories367,08732.964%276,080243,035227,374210,684
Trade Receivables255,838-1.435%259,562351,226448,540763,806
Cash & Bank Balances2,748,26212.166%2,450,1732,196,3231,940,2731,383,232
Other Current Assets906,89342.402%636,856265,24542,51051,926
Assets Held for Sale0--0000

4,278,08018.092%3,622,6713,055,8292,658,6972,409,648
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables83,09838.749%59,89166,63850,88955,520
S-T Debt & Leases507,63611.758%454,229602,426549,414553,567
Other Current Liabilities904,2628.118%836,368688,343731,560687,207
Liab asso w/ Assets Held for Sale0--0000

1,494,99610.700%1,350,4881,357,4071,331,8631,296,294
Net Current Assets2,783,08422.485%2,272,1831,698,4221,326,8341,113,354
Total Assets Less Current Liabilities4,012,99813.301%3,541,8923,005,3312,618,3902,411,792
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases3,898-34.454%5,9478,54700
Other Non-current Liabilities90,388-6.759%96,94086,003101,892105,031

94,286-8.360%102,88794,550101,892105,031
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital63,8120.571%63,45064,80064,42468,033
  Reserves3,562,69115.608%3,081,6892,552,9052,155,9431,926,051
  Others0--0000
Shareholders' Funds3,626,50315.305%3,145,1392,617,7052,220,3671,994,084
Non-controlling Interests292,209-0.564%293,866293,076296,131312,677
Others0--0000

3,918,71213.949%3,439,0052,910,7812,516,4982,306,761
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments532,90318.224%450,758482,495473,870463,879
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 01/11/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 399,765
%Change14.910%
EPS / (LPS)RMB 0.499
NBV Per Share (¥)RMB 4.383
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.